Retrieve available abstracts of 41 articles: HTML format
Single Articles
June 2025
ZHANG L, Gao Z, Pan H, Li R, et al BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR
T-Cell Therapy.
N Engl J Med. 2025;392:2282-2284. PubMed
XUE W, Jones DS Debating Race and the Diagnosis of Anemia - How Medicine Moved Away from
Race-Based Standards.
N Engl J Med. 2025;392:2168-2173. PubMed
March 2025
ENGLISH SW, Delaney A, Fergusson DA, Chasse M, et al Liberal or Restrictive Transfusion Strategy in Aneurysmal Subarachnoid
Hemorrhage.
N Engl J Med. 2025;392:1079-1088. PubMedAbstract available
August 2024
WANDER SA, Thai JN, Wirth LJ, Soto DE, et al Case 26-2024: A 59-Year-Old Woman with Aphasia, Anemia, and a Breast Mass.
N Engl J Med. 2024;391:747-757. PubMed
TURGEON AF, Fergusson DA, Clayton L, Patton MP, et al Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain
Injury.
N Engl J Med. 2024;391:722-735. PubMedAbstract available
ISRAEL A, Raz I, Vinker S, Magen E, et al Type 2 Diabetes in Patients with G6PD Deficiency.
N Engl J Med. 2024;391:568-569. PubMed
FRANGOUL H, Hobbs WE, Locatelli F Studies of Exagamglogene Autotemcel - Age and Place. Reply.
N Engl J Med. 2024;391:572. PubMed
MIN J Studies of Exagamglogene Autotemcel - Age and Place.
N Engl J Med. 2024;391:571-572. PubMed
June 2024
RISITANO AM, Kulasekararaj AG, Peffault de Latour R Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria. Reply.
N Engl J Med. 2024;390:2033-2034. PubMed
MARNAS P, Zarogiannis SG Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria.
N Engl J Med. 2024;390:2033. PubMed
HILLMEN P Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria.
N Engl J Med. 2024;390:2032-2033. PubMed
May 2024
OLSON R, Vaidya A, Aung KK, Merz LE, et al Adding Insult to Injury.
N Engl J Med. 2024;390:e51. PubMed
FRANGOUL H, Locatelli F, Sharma A, Bhatia M, et al Exagamglogene Autotemcel for Severe Sickle Cell Disease.
N Engl J Med. 2024;390:1649-1662. PubMedAbstract available
LOCATELLI F, Lang P, Wall D, Meisel R, et al Exagamglogene Autotemcel for Transfusion-Dependent beta-Thalassemia.
N Engl J Med. 2024;390:1663-1676. PubMedAbstract available
DALEY GQ Welcoming the Era of Gene Editing in Medicine.
N Engl J Med. 2024;390:1642-1645. PubMed
MCCUNE JM, Kiem HP Extending Gene Medicines to All in Need.
N Engl J Med. 2024;390:1721-1722. PubMed
April 2024
LAM WK, Yip SF Drug-Induced Oxidative Hemolysis.
N Engl J Med. 2024;390:1513. PubMed
March 2024
PEFFAULT DE LATOUR R, Roth A, Kulasekararaj AG, Han B, et al Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria.
N Engl J Med. 2024;390:994-1008. PubMedAbstract available
CARSON JL, Brooks MM, Hebert PC Transfusion Strategy in Myocardial Infarction and Anemia. Reply.
N Engl J Med. 2024;390:961-962. PubMed
KHAN MS, Spertus JA, Chan PS Transfusion Strategy in Myocardial Infarction and Anemia.
N Engl J Med. 2024;390:960-961. PubMed
CHAPALAIN X, Aubron C Transfusion Strategy in Myocardial Infarction and Anemia.
N Engl J Med. 2024;390:960. PubMed
December 2023
FREEDMAN SB, van de Kar NCAJ, Tarr PI Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome. Reply.
N Engl J Med. 2023;389:2500. PubMed
JACOBS FM Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome.
N Engl J Med. 2023;389:2499-2500. PubMed
NORIS M, Remuzzi G Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome.
N Engl J Med. 2023;389:2499. PubMed
November 2023
AZAR SS, Simeone FJ, Jarolimova J, Nussbaum EZ, et al Case 37-2023: A 29-Year-Old Man with Sickle Cell Disease and Right Hip Pain.
N Engl J Med. 2023;389:2088-2096. PubMed
CARSON JL, Brooks MM, Hebert PC, Goodman SG, et al Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.
N Engl J Med. 2023 Nov 11. doi: 10.1056/NEJMoa2307983. PubMedAbstract available
ZACHRISON KS, Kamalian S, Sykes DB, Brunker PAR, et al Case 34-2023: A 49-Year-Old Woman with Loss of Consciousness and
Thrombocytopenia.
N Engl J Med. 2023;389:1804-1811. PubMed
October 2023
FREEDMAN SB, van de Kar NCAJ, Tarr PI Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome.
N Engl J Med. 2023;389:1402-1414. PubMed
August 2023
SHARMA A, Boelens JJ, Cancio M, Hankins JS, et al CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.
N Engl J Med. 2023;389:820-832. PubMedAbstract available
FUKUSHIMA H, Matsumoto M Cold Agglutinin Syndrome.
N Engl J Med. 2023;389:642. PubMed
SCHREIBER AR, Santos J, McMahon B, Buckner TW, et al A Case of Fetal-Induced Graft-versus-Host Disease.
N Engl J Med. 2023;389:668-670. PubMed
VAN BAARLE FLF, Biemond BJ, Vlaar APJ Platelet Transfusion in Patients with Thrombocytopenia. Reply.
N Engl J Med. 2023;389:480. PubMed
GILSTAD CW Platelet Transfusion in Patients with Thrombocytopenia.
N Engl J Med. 2023;389:479-480. PubMed
WARNER MA, Hess AS, Frank SM Platelet Transfusion in Patients with Thrombocytopenia.
N Engl J Med. 2023;389:479. PubMed
SHIBUSAWA M, Tanimoto T Platelet Transfusion in Patients with Thrombocytopenia.
N Engl J Med. 2023;389:478-479. PubMed
June 2023
BLOCK J, Rashkova C, Castanon I, Zoghi S, et al Systemic Inflammation and Normocytic Anemia in DOCK11 Deficiency.
N Engl J Med. 2023 Jun 21. doi: 10.1056/NEJMoa2210054. PubMedAbstract available
April 2023
VAN DIJCK R, Goncalves Silva AM, Rijneveld AW Luspatercept as Potential Treatment for Congenital Sideroblastic Anemia.
N Engl J Med. 2023;388:1435-1436. PubMed
CHILDERHOSE JE, Cronin RM, Klatt MD, Schamess A, et al Treating Chronic Pain in Sickle Cell Disease - The Need for a Biopsychosocial
Model.
N Engl J Med. 2023;388:1349-1351. PubMed
CHASSE M, Fergusson DA, Tinmouth A, Acker JP, et al Effect of Donor Sex on Recipient Mortality in Transfusion.
N Engl J Med. 2023;388:1386-1395. PubMedAbstract available
March 2023
BURTSCHER M Oxygen Delivery in the Treatment of Anemia.
N Engl J Med. 2023;388:e38. PubMed
LEE AI, Heidari P, Fenves AZ, Bardia A, et al Case 8-2023: A 71-Year-Old Woman with Refractory Hemolytic Anemia.
N Engl J Med. 2023;388:1032-1041. PubMed